Transient adult T-cell leukemia/lymphoma picture during varicella infection in an HTLV-1 carrier.
M. D’Incan(Centre Hospitalier Universitaire de Clermont-Ferrand), A Fléchaire, Gilles Audoly(Centre National de la Recherche Scientifique), J. Brunot, Bernard Verrier(Lyon 1 Université), P. Combemale(Centre Léon Bérard), Claude Des̀granges(Inserm), D. Garín(University of Fribourg)
PubMed
April 1, 1994
Cited by 10
Related Papers
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
|The Lancet Oncology|2015|432
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
|Science Translational Medicine|2013|246
Blastic NK-Cell Lymphomas (Agranular CD4+CD56+ Hematodermic Neoplasms)
|American Journal of Clinical Pathology|2005|234
Blastic NK-Cell Lymphomas (Agranular CD4+CD56+ Hematodermic Neoplasms): A Review
|American Journal of Clinical Pathology|2005|233